These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38368378)

  • 1. The role of perfusion, grey matter volume and behavioural phenotypes in the data-driven classification of cognitive syndromes.
    Vipin A; Lee BTK; Kumar D; Soo SA; Leow YJ; Ghildiyal S; Lee FPHE; Hilal S; Kandiah N
    Alzheimers Res Ther; 2024 Feb; 16(1):40. PubMed ID: 38368378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disrupted Balance of Gray Matter Volume and Directed Functional Connectivity in Mild Cognitive Impairment and Alzheimer's Disease.
    Xiong Y; Ye C; Sun R; Chen Y; Zhong X; Zhang J; Zhong Z; Chen H; Huang M
    Curr Alzheimer Res; 2023; 20(3):161-174. PubMed ID: 37278043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis.
    Willette AA; Calhoun VD; Egan JM; Kapogiannis D;
    Psychiatry Res; 2014 Nov; 224(2):81-8. PubMed ID: 25194437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.
    Millar PR; Gordon BA; Luckett PH; Benzinger TLS; Cruchaga C; Fagan AM; Hassenstab JJ; Perrin RJ; Schindler SE; Allegri RF; Day GS; Farlow MR; Mori H; Nübling G; ; Bateman RJ; Morris JC; Ances BM
    Elife; 2023 Jan; 12():. PubMed ID: 36607335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patterns.
    Lerch O; Ferreira D; Stomrud E; van Westen D; Tideman P; Palmqvist S; Mattsson-Carlgren N; Hort J; Hansson O; Westman E
    Alzheimers Res Ther; 2024 Jul; 16(1):153. PubMed ID: 38970077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain imaging correlates of mild cognitive impairment and early dementia in patients with type 2 diabetes mellitus.
    Groeneveld O; Reijmer Y; Heinen R; Kuijf H; Koekkoek P; Janssen J; Rutten G; Kappelle L; Biessels G;
    Nutr Metab Cardiovasc Dis; 2018 Dec; 28(12):1253-1260. PubMed ID: 30355471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
    Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
    Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grey matter volume and CSF biomarkers predict neuropsychological subtypes of MCI.
    Lefort-Besnard J; Naveau M; Delcroix N; Decker LM; Cignetti F;
    Neurobiol Aging; 2023 Nov; 131():196-208. PubMed ID: 37689017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
    Jack CR; Lowe VJ; Senjem ML; Weigand SD; Kemp BJ; Shiung MM; Knopman DS; Boeve BF; Klunk WE; Mathis CA; Petersen RC
    Brain; 2008 Mar; 131(Pt 3):665-80. PubMed ID: 18263627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia.
    Vipin A; Kumar D; Soo SA; Zailan FZ; Leow YJ; Koh CL; Ng ASL; Ng KP; Kandiah N
    Alzheimers Res Ther; 2023 Jun; 15(1):103. PubMed ID: 37270543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.
    Toledo JB; Weiner MW; Wolk DA; Da X; Chen K; Arnold SE; Jagust W; Jack C; Reiman EM; Davatzikos C; Shaw LM; Trojanowski JQ;
    Acta Neuropathol Commun; 2014 Mar; 2():26. PubMed ID: 24602322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-Cognition Associations in Older Patients With Remitted Major Depressive Disorder or Mild Cognitive Impairment: A Multivariate Analysis of Gray and White Matter Integrity.
    Marawi T; Zhukovsky P; Rashidi-Ranjbar N; Bowie CR; Brooks H; Fischer CE; Flint AJ; Herrmann N; Mah L; Pollock BG; Rajji TK; Tartaglia MC; Voineskos AN; Mulsant BH;
    Biol Psychiatry; 2023 Dec; 94(12):913-923. PubMed ID: 37271418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia.
    Malpetti M; Cope TE; Street D; Jones PS; Hezemans FH; Mak E; Tsvetanov KA; Rittman T; Bevan-Jones WR; Patterson K; Passamonti L; Fryer TD; Hong YT; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2023 Aug; 146(8):3221-3231. PubMed ID: 36883644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of dynamic (11)C-PIB PET and structural MRI improves diagnosis of Alzheimer's disease.
    Liu L; Fu L; Zhang X; Zhang J; Zhang X; Xu B; Tian J; Fan Y
    Psychiatry Res; 2015 Aug; 233(2):131-40. PubMed ID: 26095348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between arterial stiffening and brain structure, perfusion, and cognition in the Whitehall II Imaging Sub-study: A retrospective cohort study.
    Suri S; Chiesa ST; Zsoldos E; Mackay CE; Filippini N; Griffanti L; Mahmood A; Singh-Manoux A; Shipley MJ; Brunner EJ; Kivimäki M; Deanfield JE; Ebmeier KP
    PLoS Med; 2020 Dec; 17(12):e1003467. PubMed ID: 33373359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.